Ladenburg Thalmann Financial Services’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	60	–	–	﹤0.01%	5714
2019 Q3	$0	Sell	60 -1,933	-97%	-$9.66K	﹤0.01%	5661
2019 Q2	$9K	Hold	1,993	–	–	﹤0.01%	4507
2019 Q1	$11K	Hold	1,993	–	–	﹤0.01%	4348
2018 Q4	$7K	Buy	1,993 +1,917	+2,522%	+$6.65K	﹤0.01%	4485
2018 Q3	$0	Hold	76	–	–	﹤0.01%	5560
2018 Q2	$0	Hold	76	–	–	﹤0.01%	5228
2018 Q1	$0	Buy	+76	New	+$629	﹤0.01%	5355
2016 Q3	–	Sell	-636	Closed	-$27K	–	4968
2016 Q2	$27K	Sell	636 -635	-50%	-$34.6K	﹤0.01%	3149
2016 Q1	$84K	Sell	1,271 -1,907	-60%	-$99.5K	﹤0.01%	2199
2015 Q4	$198K	Hold	3,178	–	–	﹤0.01%	1592
2015 Q3	$213K	Buy	3,178 +293	+10%	+$23.9K	﹤0.01%	1447
2015 Q2	$281K	Hold	2,885	–	–	0.01%	1370
2015 Q1	$270K	Buy	2,885 +762	+36%	+$64.9K	0.01%	1372
2014 Q4	$189K	Buy	2,123 +191	+10%	+$13.9K	﹤0.01%	1469
2014 Q3	$133K	Hold	1,932	–	–	﹤0.01%	1450
2014 Q2	$111K	Hold	1,932	–	–	﹤0.01%	1542
2014 Q1	$77K	Hold	1,932	–	–	﹤0.01%	1667
2013 Q4	$81K	Buy	+1,932	New	+$56K	﹤0.01%	1599
2013 Q3	–	Sell	-318	Closed	-$17K	–	3908
2013 Q2	$17K	Buy	+318	New	+$13.9K	﹤0.01%	2447

Other funds holding MACK

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MACK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Merrimack Pharmaceuticals, Inc. (MACK) position steady in Q4 2019 at 60 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5714.

Ladenburg Thalmann Financial Services first reported a position in MACK in Q2 2013 and has held it in 20 quarters since. The position peaked at $281K in Q2 2015. 48 funds tracked by Wall St. Rank hold MACK as of Q4 2019.

Ladenburg Thalmann Financial Services held 60 shares of Merrimack Pharmaceuticals, Inc. worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services left its Merrimack Pharmaceuticals, Inc. share count unchanged in Q4 2019.
Merrimack Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5714 holding.
Ladenburg Thalmann Financial Services first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and has held it in 20 quarters since.
Ladenburg Thalmann Financial Services's Merrimack Pharmaceuticals, Inc. position peaked at $281K in Q2 2015.
48 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.